ANG Lifesciences India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 ,inter alia, to consider and approve the Standalone & Consolidated ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
ANG Lifesciences India Ltd has scheduled a Board meeting for 30th May 2026 at 5:00 PM at their registered office in Amritsar. The meeting will consider and approve the Standalone and Consolidated Audited Financial Results for the quarter and year ended 31st March 2026. The company has also closed its trading window from 1st April 2026, which will reopen 48 hours after the results are made public. This is a routine regulatory intimation under SEBI Listing Regulations for quarterly and annual financial results disclosure.
This is a standard pre-result announcement notice. The scheduled meeting will determine the financial performance for Q4 and full year FY2026. The trading window closure indicates insiders cannot trade until results are disclosed, which is typical for this type of meeting.